NA
NMTC icon

NewEdge Advisors’s NeuroOne Medical Technologies NMTC Stock Holding History

NewEdge Advisors’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-397
Closed -$2.12K – 3837
2023
Q3 		$2.12K Buy
+397
New +$2.66K ﹤0.01% 3031

Other funds holding NMTC

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WAAG
Wealth Alliance Advisory Group Wichita, Kansas $691M AUM 24.37% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

NewEdge Advisors's NMTC Position: Q4 2023 in Review

NewEdge Advisors sold out of NeuroOne Medical Technologies (NMTC) in Q4 2023, closing a stake of 397 shares — an estimated $2.12K sold.

NewEdge Advisors first reported a position in NMTC in Q3 2023 and held it in 1 quarter. The position peaked at $2.12K in Q3 2023. 20 funds tracked by Wall St. Rank hold NMTC as of Q4 2023.

  • NewEdge Advisors reported no remaining NeuroOne Medical Technologies position as of Q4 2023 after selling out during the quarter.
  • NewEdge Advisors sold 397 NeuroOne Medical Technologies shares in Q4 2023, an estimated $2.12K.
  • NewEdge Advisors first reported a position in NeuroOne Medical Technologies in Q3 2023 and held it in 1 quarter.
  • NewEdge Advisors's NeuroOne Medical Technologies position peaked at $2.12K in Q3 2023.
  • 20 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q4 2023.

Based on NewEdge Advisors's 13F filing for Q4 2023, filed 13 Feb 2024.